Individualized chemoradiotherapy for locally advanced nasopharyngeal carcinoma
10.3760/cma.j.issn.1673-422X.2011.09.009
- VernacularTitle:局部晚期鼻咽癌放化疗个体化的探讨
- Author:
Siqia CHEN
;
Derui LI
- Publication Type:Journal Article
- Keywords:
Nasopharyngeal neoplasms;
Radiotherapy;
Drug therapy
- From:
Journal of International Oncology
2011;38(9):670-673
- CountryChina
- Language:Chinese
-
Abstract:
Nasopharyngeal carcinoma (NPC) is sensitive to radiotherapy and chemotherapy.Combined chemoradiotherapy improved the survival of the patients with locally advanced NPC.However,a part of these patients did not gain the survival benefit from the combined chemoradiotherapy because of the additional serious adverse reaction.In order to achieve the best therapeutic gain after balancing the benefit and cost,all kinds of influencing factors of individualized chemoradiotherapy including the clinical and biological molecular factors which has a broad developing prospect must also be considered.
